Drug intelligence / Profile preview

Novabac

Development stage
Unknown
Lead developer
Belfast Health and Social Care Trust
Modality
Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration
Topical
01

Overview

Novabac is a topical antibacterial skin wash containing 5% tea tree oil (TTO), derived from the plant *Melaleuca alternifolia*, as its active ingredient. Developed by researchers at the Belfast Health & Social Care Trust, it is designed for the prevention of methicillin-resistant *Staphylococcus aureus* (MRSA) colonization in critically ill adults within intensive care units (ICUs). The mechanism of action involves the disruption of the bacterial cell membrane and the inhibition of microbial respiration, providing a natural alternative to standard antiseptic washes. Clinical evaluation includes a randomized controlled trial (ISRCTN65190967) comparing its efficacy against standard care for reducing MRSA acquisition.

Brand names
NovabacNovabac 5% Skin Wash
Other names
tea tree oilTTOMelaleuca alternifolia oil

Beyond the preview

Go deeper on Novabac.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novabac.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call